This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Japan's Medilabo triumphs in patent appeal as Indian court overturns controller's refusal

By Freny Patel ( November 26, 2025, 00:18 GMT | Insight) -- Japan's Medilabo RFP scored a win as an Indian court set aside a patent refusal, ruling the Controller of Patents erred by confusing a patentable drug composition with a non-patentable treatment method.Japan's Medilabo RFP scored a win when an Indian court issued a directive setting aside a patent refusal order and directed a fresh review of the clinical-stage biopharmaceutical company's application for a prophylactic or therapeutic drug composition....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login